Novonix Limited (ASX:NVX), a battery materials and technology company, lodged an Appendix 3H Notification of Cessation of Securities with the ASX on 27 May 2026.

The notice confirms that 2,932,881 performance rights under ASX security code NVXAD have ceased to exist. The reason for cessation is the lapse of a conditional right to securities because the conditions have not been, or have become incapable of being, satisfied.

No consideration is being paid by the entity for the cessation. Following the cessation, NVX has 862,227,757 fully paid ordinary shares on issue.

Appendix 3H notifications are part of the standard suite of Capital Structure disclosures on the ASX. They are designed to keep the market informed about changes in the number of unquoted Equity and Debt securities on issue, including the cessation of performance rights, Options, share rights and other instruments.

For Novonix, which has multiple classes of unquoted securities outstanding, regular Appendix 3H disclosures are an important part of maintaining an accurate picture of its capital structure.

Why This ASX Announcement Matters

Performance rights are a common form of equity-based long-term incentive used by ASX-listed companies. When performance hurdles are not met, the rights can lapse, reducing potential future dilution.

For Novonix, the cessation of 2,932,881 performance rights modestly reduces potential future share issuance and provides updated transparency on its capital structure, which currently includes a range of performance rights, options, share rights, convertible notes and convertible debentures.

Performance rights are typically issued under employee or executive incentive plans, with vesting conditions tied to specific performance hurdles. When those hurdles are not met, the rights lapse and the associated potential for share issuance is removed.

For investors, the lapse of unvested performance rights can be a small but meaningful positive in dilution terms, particularly when considered alongside other components of the capital structure.

How This Could Affect Novonix Shares

The immediate effect of the cessation on the NVX share price is likely to be limited, given that performance rights are unquoted instruments. However, reduced potential future dilution is generally viewed as a marginal positive over the medium term.

Investors should also consider Novonix’s broader capital structure when assessing dilution risk. Convertible notes and debentures, in particular, can have a more material impact depending on conversion terms and conditions.

Beyond performance rights, Novonix has options, share rights, convertible notes and convertible debentures outstanding. The fully diluted share count, accounting for these instruments, can be materially higher than the headline FPO count.

Investors who incorporate fully diluted capital structure analysis into their valuation work should track each class of unquoted security and its respective conversion or exercise mechanics.

Industry and Market Context

Novonix is engaged in the development and production of high-performance materials, equipment and services for the global battery industry. Its activities span synthetic graphite anode materials, cell testing equipment and related Research and Development.

The global Lithium-Ion Battery materials sector is a focus of policy and investor attention, particularly given the role of electrification of transport, energy storage systems and the broader transition to lower-carbon energy. Companies with US and Australian operating footprints and exposure to critical minerals Supply chains have attracted strategic interest.

The global battery materials sector continues to evolve rapidly, with Demand for high-quality anode and cathode materials underpinned by electric vehicle adoption and energy storage system growth. Synthetic graphite anode materials in particular have been identified as an area of strategic importance for several governments.

Novonix’s positioning in the United States, alongside its Australian-based research and development activities, places it within the broader critical minerals and advanced materials theme that has attracted significant policy and investor interest.

Investor Reaction and Market Watch Points

Investors will continue to watch Novonix’s broader operational milestones, including production scale-up, customer agreements, financing arrangements and any strategic developments. The capital structure remains an important consideration given the range of unquoted convertible securities.

Subsequent Appendix 2A, 3H and 3G filings will provide ongoing visibility on changes to Issued Capital.

Investors who follow Novonix closely will be considering not only the latest cessation of performance rights but also the broader pipeline of customer qualifications, the timing of Capital Expenditure decisions and the company’s relationship with government programs supporting critical minerals development.

Capital market access remains a key consideration for development-stage battery materials companies, and any potential equity or debt issuance will be carefully scrutinised by investors.

Risks and Uncertainties

Novonix is a development-stage battery materials Business that faces commercialisation, technology, customer and financing risks. The pace of customer qualification, production scale-up and capital expenditure can vary materially from initial plans.

The cessation of performance rights, while reducing potential future dilution, does not, by itself, change the operational trajectory or financial position of the company.

Novonix’s commercialisation pathway involves multiple risks, including ability to secure long-term offtake agreements, ability to fund and complete capital expenditure programs, technology and execution risks, and dependence on broader macroeconomic conditions affecting EV and battery demand.

Investors should review Novonix’s periodic financial reports and operational updates for a fuller picture of these risks.

What Happens Next?

Investors should watch for updates on Novonix’s commercial agreements, capital management decisions, technology milestones and any further changes in issued capital. The Appendix 3H is part of standard ongoing disclosure rather than a strategic announcement.

Future operational updates from Novonix are likely to focus on customer agreements, sample qualification programs, capital expenditure plans and milestones related to its US production Assets. Each of these areas can have a meaningful impact on the company’s narrative and valuation.

Investors should also watch for any updates regarding the conversion or Maturity of outstanding convertible notes and debentures, which form a material part of the company’s overall capital structure.

Broader ASX Context and Investor Considerations

Beyond the specific details of this ASX announcement, Novonix Limited (ASX: NVX) sits within a broader Australian market environment that continues to be shaped by a range of macroeconomic and structural forces. These include the trajectory of interest rates set by the Reserve Bank of Australia, the strength of consumer and business confidence, the performance of key trading partners, and the evolution of regulatory and policy frameworks relevant to battery materials, anode technology and the critical minerals supply chain.

ASX investors evaluating NVX should also consider how the latest disclosure fits within the wider information mosaic that has been built up over time. This includes prior ASX announcements, financial statements, broker research where available, peer comparisons, and any commentary from management at investor presentations or annual general meetings. Each disclosure adds to the picture without necessarily transforming it.

Liquidity and trading dynamics are another important dimension for NVX. The depth of the order book, the bid-ask spread and the typical daily turnover all influence how easily investors can enter or exit positions at their desired price. These factors can be especially relevant for retail investors and self-managed Superannuation funds that may not have the same execution tools as larger institutional participants.

Investors should also be aware that ASX-listed companies are subject to ongoing continuous disclosure obligations. This means that material developments that could reasonably be expected to influence the share price must be disclosed promptly via the ASX announcements platform. Such disclosures provide the bedrock of investor decision-making and supplement information available from independent research, regulatory filings and broader market data.

Portfolio Diversification is another consideration that often arises when evaluating any single ASX-listed entity. Concentrating exposure to one stock or sector can produce both upside and downside surprises that may not align with an investor’s broader objectives, while a diversified approach can help smooth returns over time. Discussing portfolio construction with a qualified financial adviser can be valuable, especially for investors with complex circumstances or specific income, growth or capital preservation goals.

Tax considerations are also relevant when interpreting ASX announcements such as distributions, share repurchases, equity issuances and changes in substantial holdings. Different events may have different implications across income, capital gains and franking Credit considerations, and these may vary depending on whether shares are held by individuals, trusts, companies or self-managed superannuation funds. Investors are encouraged to seek personal tax advice where the outcome of an announcement is material to their circumstances.

It is also helpful for investors to think about the role of ASX disclosures in supporting overall market integrity. Australia’s continuous disclosure regime, combined with substantial holder rules, director interest notifications and capital change disclosures, is designed to ensure that all Market Participants have access to the same information at the same time. This level playing field underpins fair price discovery and supports confidence in the ASX as a venue for capital formation.

From a risk management perspective, the latest update for NVX should be considered alongside an investor’s overall position sizing, time horizon and Risk tolerance. Even when an individual announcement appears procedural, the cumulative impact of multiple disclosures can shape sentiment over time. A disciplined approach that combines Fundamental Analysis with attention to disclosure flow is generally more robust than reacting to each filing in isolation.

Finally, it is important to recognise that any single announcement, including this one, is best interpreted as part of a longer-term review of the company. Whether the disclosure is procedural, transactional or strategic, its full significance is generally only apparent in the context of subsequent decisions, market reactions and operational outcomes over the months and years that follow.

Final Takeaway

The Appendix 3H from Novonix (ASX: NVX) confirms the lapse of 2,932,881 NVXAD performance rights, reducing potential future dilution by a small Margin.

For ASX investors, the announcement helps refresh the picture of Novonix’s capital structure but should be considered alongside operational, financing and commercial developments.

The Appendix 3H disclosure from Novonix is a modest but useful update on the company’s capital structure. It contributes to a more accurate picture of fully diluted ownership and reflects the operation of standard long-term incentive arrangements.

For longer-term investors, however, the underlying value drivers remain in the company’s ability to execute its battery materials strategy and generate sustainable commercial outcomes.